Method for producing autologous platelet-rich plasma

Details Method for producing autologous platelet-rich plasma Method for producing autologous platelet-rich plasma

2001-11-16

2003-11-18

Reifsnyder, David A. (Department: 1723)

Liquid purification or separation

Processes

Separating

C210S787000, C210S789000, C210S745000, C424S529000, C424S530000, C424S531000, C424S532000, C435S366000, C494S037000

Reexamination Certificate

active

06649072

ABSTRACT:

BACKGROUND AND SUMMARY OF THE INVENTION
The present invention is directed to a method of processing blood to create an autologous platelet rich blood composition useful in the enhancement of bone fusion and soft tissue repair in animals.


REFERENCES:
patent: 5165938 (1992-11-01), Knighton
patent: 5211850 (1993-05-01), Shettigar et al.
patent: 5423738 (1995-06-01), Robinson et al.
patent: 5733545 (1998-03-01), Hood, III
patent: 5858238 (1999-01-01), McRea et al.
patent: 6010627 (2000-01-01), Hood, III
patent: 6214338 (2001-04-01), Antanavich et al.
patent: 6303112 (2001-10-01), Worden
patent: 6444228 (2002-09-01), Baugh et al.
patent: 2002/0054901 (2002-05-01), Gainey et al.
patent: 2002/0147098 (2002-10-01), Dolecek
patent: 0 105 014 (1984-04-01), None
patent: 0 128 849 (1984-12-01), None
patent: 0 190 018 (1985-01-01), None
patent: 2 472 385 (1981-07-01), None
patent: 2 533 438 (1984-03-01), None
patent: 2 146 335 (1985-04-01), None
patent: WO 87/01728 (1987-03-01), None
Knighton, D. R. et al., “Role of Platelets and Fibrin in Healing Sequence,” 196:4Annals of Surgery3790-388 (Oct. 1982).
Grotendorst, G.., “Can Collegen Metabolism be Controlled?” 24:9J. TraumaS5-6, S49-54 (Sep. 1984) .
Grotendorst, G., et al. “Molecular Mediators of Tissue Repair,”Surgical Sci., Serv. Ch. 2 p. 20-40 (1984).
Edited J. Linman; “Hemorrhagic Disorders”; Hematology, 849-894 (McMillan 1975).
Edited T. Hunt, et al.; “Role of Platelets in Wound Healing: Demonstration of Angiogenic Activity”, Soft and Hard Tissue Repair, 380-394 (Praeger pre 1990).
Hemostasis andBloodCoagulation. (p. 99-111) (undated).
Grotendorst, G., et al. “Platelet-derived Growth Factor is a Chemoattractant for Vascular Smooth Muscle Cells,” 113J. Cellular Phys., 261-266 (1982).
Knighton, D. et al., Classification and Treatment of Chronic Nonhealing Wounds, 204:3Annals of Surgery322-330 (Sep. 1986).
Curatech, Inc., Platelet Derived Wound Healing Formula (PDWHF), 1-14 (undated).
Ross, R. and Vogel, A., “The Platelet Derived Growth Factor,” (undated.
Zetter, B. and Antoniades, H., Stimulation of Human Vascular Endothelial Cell Growth by a Platelet-Derived Growth Factor and Thrombin, 11J. Supramolecular Structure361-370 (1979).
Banda, J., et al. “Isolation of a Nonmitogenic Angiogenesis Factor from Wound Fluid,” 79Proc. Nat'l Acad. Sci. USA, 7773-7777 (Dec. 1982).
“Polypeptide Transforming Growth Factors Isolated from Bovine Sources and Used for Wound Healing In Vivo,” 219Science1329-1331 (Mar. 18, 1983).
Levi-Montalcini, “Repair Factor F.C.P.” 1-41 (Oct. 1986).
Cope, L., Surgeon's Treatment Lets Patients heal Stubborn Wounds with OwnBlood, from Mpls Star and Trib Nov. 12, 1984.
Grotendorst, G., et al. “Stimulation of Granulation Tissue Formation by PDGF in Normal and Diabetic Rats,”Laboratory of Dev. Biology and Anomalies NIH(undated).
Time Magazine article of Oct. 7, 1985 on work done at Harvard Medical School.
Radioimmunoassay of human serum growth factor for Balb/c-3T3 cells; Derivation from Platelets by Antoniades et al. from vol. 74, Proc. Natl. Acad. Sci, U.S.A. (May 1977).
Robson, M., et al., “Platelet-Derived Growth Factor BB for the Treatment of Chronic Pressure Ulcers,” 339The Lancet23-25 (Jan. 4, 1992).
Leitzel, K., et al. “Growth Factors and Wound Healing in the Hamster,” 11:6J. Dermatol. Surg. Oncol., 617-622 (Jun. 1985).
Hunt, T., “Can Repair Processes by Stimulated by Modulators (Cell Growth, Angiogenic Factors, etc.) without Adversely Affecting Normal Processes ?” 24Frontiers in Understanding Burn InjuryS39-46 (Sep. 1984).
Senior, R., et al. “Chemotactic Activity of Platelet Alphia Granule Proteins for Fibroblasts, ” 96J. Cell Bio.,382-385 (Feb. 1983).
Johnson, A., et al., “Platelet Derived Growth Factor: Identification of Constituent Polypeptide Chains,” 104:1Biochem and Biophys. Res. Comm., 66-74 (Jan. 15, 1982).
Thornton, J. W., et al. “Epidermal Growth Factor in the Healing of Second Degree Burns: A Controlled Animal Study, ” 8:Burns156-160 (1981).
Greaves, M., “Lacke of Effect of Topically Applied Epidermal Growth Factor (EGF) on Epidermal Growth in Man In Vivo,” 5:Clin. And Exper. Derma., 101-103 (Aug. 1979)..
Devel, T., et al., “Platelet Factor 4 is Chemotactic for Neurtrophils and Monocytes, ” 78:7Prac. Natl. Acad. Sci. USA, 4584-4587 (Jul. 1981).
Niall, M., et al., “The Effect of Epidermal Growth Factor on Wound Healing in Mice,” 83J. Surg. Res.164-169 (1982).
Carpenter, G., “The Regulation of Cell Proliferation: Advances in the Biology and Mechanism of Action of Epidermal Growth Factor,” 71:5J. Invest. Derma., 283-288 (1978).
Frati, L., “Selective Binding of the Epidermal Growth Factor and its Specific Effects on the Epithelial Cells of the Cornea,” 14Exp. Eye Res.134-141 (1972).
U.S. patent application Ser. No. 10/115,623, Brandt et al., filed Apr. 4, 2002.

Affiliated with

Also associated with

Rating

Method for producing autologous platelet-rich plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for producing autologous platelet-rich plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing autologous platelet-rich plasma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3124696